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Abstract
Background: Despite more than a decade of extensive, international efforts to characterize and understand the increased
symptom and illness-reporting among veterans of the 1991 Gulf War, concern over possible long-term health effects related to
this deployment continue. The purpose of this study was to describe the long-term hospitalization experience of the subset of
U.S. Gulf War veterans still on active duty between 1994 and 2004.
Methods: Gulf War veterans on active duty rosters as of October 1, 1994, were identified (n = 211 642) and compared with
veterans who had separated from military service and then assessed for attrition at three-year intervals during a 10-year follow-
up period, examining demographic and military service characteristics, Gulf War exposure variables, and hospitalization data.
Cox proportional hazard modeling was used to evaluate independent predictors of all-cause hospitalization among those still on
active duty and to estimate cumulative probability of hospitalization, 1994–2004, by service branch.
Results: Members of our 1994 active duty cohort were more likely to be officers, somewhat older, and married compared with
those who had separated from the military after serving in the 1991 Gulf War. Selected war-related exposures or experiences
did not appear to influence separation with the exception of in-theater presence during the brief ground combat phase. Overall
the top three diagnostic categories for hospitalizations were musculo-skeletal, injury and poisoning, and digestive disorders.
Diseases of the circulatory system and symptoms, signs, and ill-defined conditions increased proportionately over time. In-
theater hospitalization was the only significant independent predictor of long-term hospitalization risk among selected war-
related exposures or experiences examined. The cumulative probability of hospitalization was highest for Army and lowest for
Marines.
Conclusion: Our results were generally consistent with a previous hospitalization study of US Gulf War veterans for the period
August 1991 to July 1999. Although lack of a comparison group for our study limits interpretation of overall findings, intra-cohort
analyses showed no significant associations between long-term hospitalization and war-related exposures or experiences, with
the exception of in-theater hospitalization, within our active duty subset of 1991 Gulf War veterans.
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Background
Concern for the health of individuals reporting symptoms
or illnesses following service in the 1991 Gulf War led to
wide-ranging, international investigations for over more
than a decade that attempted to characterize a unique syn-
drome and/or identify possible deployment-related
causes [1-23]. Some specific exposures investigated
include smoke from oil well fires [24-28], nerve agents
released during munitions demolition at Khamisiyah,
Iraq [28-38], immunizations [12,39-48], pesticides
[41,44,45,47,49-54], chemical warfare nerve agent proph-
ylaxis [45,47,52,53,55-60], and other exposures (single or
multiple), including psychological stressors
[41,44,50,52,53,58,61-73]. While several researchers have
reported associations between some Gulf War exposures
and specific health effects [34,36,41,56], epidemiologic
studies to date have not provided strong and consistent
evidence for a causal relationship between putative expo-
sures and the full array of symptoms and illnesses associ-
ated with deployment to the 1991 Gulf War [19,66,68,74-
80].
Previous studies have examined the early postwar hospi-
talization experience of U.S. Gulf War veterans compared
with non-deployed era veterans and found no unex-
plained differences for most diagnostic categories [81,82].
Excess hospitalizations among Gulf War veterans for
some diagnoses were most often viewed as a consequence
of deferred treatment, postwar adjustment to the stresses
of war, or participation in a Gulf War health registry pro-
gram with admission to hospital for advanced diagnostic
procedures [81-85]. Investigations of the association
between specific environmental exposures and hospitali-
zation among deployed Gulf War veterans have not dem-
onstrated increased overall risk among those exposed
[26,28,29,32,33]. Lastly, longitudinal studies of mortality
among U.S. and U.K. Gulf War veterans have not shown
significant differences in overall risk of death due to dis-
ease among those deployed to the Gulf compared with
non-deployed comparison groups [30,54,86-88]. Excess
deaths due to unintentional injury (primarily motor vehi-
cle crashes) among Gulf War veterans were observed for
up to seven years post-war, but subsequently became
comparable to the risk among non-deployed [30,54].
However, a recent report suggested increased cause-spe-
cific risk of death from brain cancer among Gulf War vet-
erans potentially exposed to munitions demolition at
Khamisiyah [34].
Thus, concern over possible long-term, adverse health
outcomes from war-related exposures has persisted more
than 15 years since the end of the 1991 Gulf War. Our
study focuses on a subset of Gulf War veterans who were
on active duty as of October 1, 1994, and describes their
long-term hospitalization experience in three-year inter-
vals over the decade from 1994 to 2004. The purpose was
to characterize this active duty subset over time and exam-
ine hospitalization as an objective measure of long-term
morbidity. We evaluated the effect of selected war-related
exposures or experiences on hospitalization by service
branch, while adjusting for demographic and military
service characteristics.
Methods
All regular active duty US military personnel deployed to
the 1991 Gulf War (n = 584 341) were identified by the
Defense Manpower Data Center (DMDC), Seaside, Cali-
fornia, USA. We examined attrition over time to select a
point at which approximately 50% of this population was
still on active duty, to allow for the usual troop reductions
after a large scale combat operation and to focus on men
and women more likely to represent those continuing a
military career. Among those deployed to the Gulf War,
265 690 were still listed on active duty rosters as of Octo-
ber 1, 1994. Of this group, 1281 had no DMDC record
available for the Gulf War period, leaving 264 409 in our
study population.
Demographic and military service characteristics, selected
Gulf War exposure variables, and Department of Defense
(DoD) hospitalization data were obtained from databases
maintained at DMDC, the Naval Health Research Center
(NHRC), San Diego, California, USA, and the US Army
Center for Health Promotion and Preventive Medicine
(CHPPM), Aberdeen Proving Ground, Maryland, USA.
DMDC provided demographic and military service data,
and the following variables were used to characterize our
study population at the time of the Gulf War and at three-
year intervals during the follow-up period: age (16–22,
23–26, 27–31, 32–61; quartiles based on distribution as
of October 1, 1994), gender, marital status (single, mar-
ried, other), race (black, white, other), service (Army,
Navy, Air Force, Marine Corps), and pay grade (officer,
enlisted). In addition, military occupation was catego-
rized into 10 groups based on the DoD 2001 Occupa-
tional Conversion Index [89], and for multivariable
modeling, dichotomized into combat specialists versus
other. We used wartime demographic and military pro-
files as the basis for observing changes in our active duty
cohort and as covariates in time-to-event modeling.
Available environmental exposure data from NHRC and
CHPPM included information on potential exposure to
munitions demolition at Khamisiyah (March 10–12,
1991) and smoke from oil well fires. The basis for estab-
lishing exposure status with respect to Khamisiyah and oil
well fires has been previously described [26,33,90]. For
purposes of multivariable modeling, we used a three-level
Khamisiyah exposure variable (presumed not at risk; at
risk of exposure but not exposed; and exposed). OtherBMC Public Health 2008, 8:60 http://www.biomedcentral.com/1471-2458/8/60
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war-related exposures or experiences, including anthrax
and/or botulinum immunization, in-theater hospitaliza-
tion, and presence in theater during ground combat oper-
ations (February 24–28, 1991) were all treated as
dichotomous variables.
We assessed the distribution of wartime demographic and
military characteristics and deployment-related exposure
variables at the start of four time intervals (1995–1997,
1998–2000, 2001–2003, and 2004) based on the federal
fiscal year (FY), starting October 1 and ending September
30. For example, FY 1995 corresponds to October 1, 1994,
through September 30, 1995. We then evaluated hospital-
izations during the entire 10-year period of observation
(October 1, 1994, to September 30, 2004), as well as over
each time interval, to identify the most frequently diag-
nosed conditions and any observable trends. To reduce
possible effects of other deployments, we excluded any
service member who deployed between the end of the
Gulf War and the beginning of our period of observation
(n = 49 502). After further excluding individuals with
missing covariate data (n = 3265), our final analytic data
set for multivariable modeling (time-to-event) included
211 642 individuals.
Hospitalization data between October 1, 1994, and Sep-
tember 30, 2004, consisted of inpatient encounter records
from military treatment facilities, as well as civilian facili-
ties when costs were reimbursed by the DoD. Up to eight
discharge diagnoses are recorded for each hospitalization
based on International Classification of Diseases, 9th Revi-
sion, Clinical Modification (ICD-9-CM) codes. We included
14 major ICD-9-CM diagnostic categories related to ill-
ness or injury in our analysis, excluding congenital anom-
alies and pregnancy-related categories. In order to capture
the full array of medical conditions for which individuals
might be hospitalized, we considered both primary and
secondary diagnoses. Individuals could be counted in
multiple diagnostic categories, but just once per category.
Additionally, in-theater hospitalization data for individu-
als in our study population were also available for analy-
sis.
We used Cox proportional hazards modeling to evaluate
independent predictors of all-cause hospitalization, while
adjusting for covariates and accounting for varying
lengths of follow-up. Initial data exploration included
bivariate analyses, Kaplan-Meier survival analysis, and the
log-rank test for equality across strata to assess propor-
tionality over time for each covariate, followed by regres-
sion diagnostics to assess collinearity. Finally, potential
confounding and effect modification were assessed
through exploratory time-to-event modeling. All covari-
ates were considered eligible for inclusion in the final Cox
regression model if they did not exhibit collinearity and
met the assumption of proportional hazard over time.
Variables related to immunization, oil well fire smoke
exposure, potential nerve agent exposure, and presence in
theater during ground combat were all retained as covari-
ates, despite lack of significance, to address ongoing gen-
eral public and veteran concerns and to quantify the
influence of these exposures. We modeled the number of
months from October 1, 1994, until first hospitalization
for any cause. Observations were censored at separation
from military service, death, subsequent deployment
(Bosnia, Kosova, or Southwest Asia), or end of study
period, whichever occurred first. Analyses were performed
using SAS®  software, version 9.1 (SAS Institute, Cary,
North Carolina, USA).
The protocol for this study was reviewed and approved by
the Institutional Review Board at the Uniformed Services
University of the Health Sciences and the Naval Health
Research Center and was conducted in compliance with
all applicable federal regulations governing the protection
of human subjects in research.
Results
Table 1 compares Gulf War veterans in our active duty
study population at the beginning of the observation
period with those who had separated from military service
prior to October 1, 1994. Our active duty subset tended to
be slightly older, married, and officers. Gender and race
were comparable between the two groups. Among the
service branches, there were some notable differences,
with Navy and particularly Air Force personnel tending to
remain on active duty and Army and Marine Corps per-
sonnel more likely to have separated. Comparing occupa-
tional categories, those in electrical/mechanical repair
were more likely to remain on active duty in contrast to
those in electronics repair and combat specialists, who
were more likely to have separated from military service.
For war-related exposures, there were no substantial dif-
ferences between those who stayed on active duty and
those who separated, except for presence in the theater of
operations during the five days of ground combat. Over-
all, about 85% of deployed service members were in
theater during ground combat (data not shown). By Octo-
ber 1, 1994, about 78% of those still on active duty had
been in theater during this combat period compared with
91% of those who had separated from military service.
Table 1 also shows the distribution of demographic and
military service characteristics at three-year time intervals
for those remaining on active duty. With the exception of
age, the proportions remained relatively consistent over
time, including service branch. As expected, the oldest age
category was less represented in the population remaining
on active duty over time.BMC Public Health 2008, 8:60 http://www.biomedcentral.com/1471-2458/8/60
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Table 1: Distribution of wartime demographic and military characteristics of personnel who served in the 1991 Gulf War and 
remained on active duty, FY 1995–2004, compared with those who separated prior to FY 1995
War-time characteristic Separated Remained on active duty
<FY 1995 FY 1995 FY 1998 FY 2001 FY 2004
%%%%%
Total service members with wartime demographic profile available n = 321 806 n = 264 409 n = 179 216 n = 128 544 n = 101 591
Gender
Male 93.8 93.8 93.9 94.0 93.9
Female 6.1 6.2 6.1 6.0 6.1
Unknown 0.1 0.0 0.0 0.0 0.0
Age (years)
16–22 35.2 26.1 23.5 24.1 28.3
23–26 29.8 24.2 26.7 30.5 34.3
27–31 18.0 25.4 30.1 30.0 25.3
32–61 16.9 24.3 19.7 15.5 12.1
Unknown 0.2 0.0 0.0 0.0 0.0
Marital status
Single, never married 56.0 35.6 34.5 36.1 40.2
Married 42.8 61.7 62.8 61.3 57.4
Other 0.9 2.8 2.7 2.5 2.3
Unknown 0.3 0.0 0.0 0.0 0.0
Race
Black 21.9 24.9 25.4 25.1 25.4
White 68.6 67.7 66.9 67.1 66.6
Other 9.2 7.3 7.6 7.8 7.9
Unknown 0.2 0.1 0.1 0.1 0.1
Service
Army 49.3 43.5 42.2 41.8 43.0
Navy* 23.8 28.2 28.0 27.9 27.2
Air Force 8.7 16.2 17.6 17.9 17.4
Marine Corps 18.3 12.2 12.2 12.4 12.4
Pay grade
Commissioned officer 6.0 13.4 14.7 16.1 16.7
Warrant officer 0.8 2.0 1.9 1.8 1.6
Enlisted 93.2 84.7 83.3 82.2 81.7
Unknown 0.0
Primary military occupation grouping
Combat specialties 28.8 23.7 24.5 25.2 25.9
Communications, intelligence 10.6 9.9 9.9 9.9 9.8
Craftsworkers 3.6 3.4 3.3 3.2 3.2
Electronics repair 19.6 9.5 9.3 9.0 8.7
Electrical/mechanical repair 7.6 20.4 20.0 19.9 19.6
Functional support 10.4 12.3 12.2 12.1 11.9
Health care specialists 4.5 6.5 6.7 6.7 6.8
Non-occupational 1.3 2.7 2.6 2.6 2.8
Other technical specialists 2.0 2.3 2.4 2.3 2.1
Service support 10.6 9.2 9.1 9.1 9.2
Unknown 1.0 0.0 0.0 0.0 0.0
War-related exposures
Anthrax immunization 0.4 0.4 0.4 0.4 0.4
Botulinum immunization (<0.1) 0.4 0.4 0.4 0.4
Exposed to Khamisiyah March 10–12, 1991 13.7 12.5 12.2 12.1 12.4
Exposed to oil well fire 1991 65.1 61.0 61.0 61.0 61.4
In-theater hospitalization 2.9 2.1 2.1 2.0 2.0
In theater during combat period 90.9 78.1 78.3 78.5 78.8
Returned to the Gulf between end of war and FY 1995 18.7 18.9 17.5 18.6
Subsequent deployment (Bosnia, Kosovo, SW Asia) 15.0 20.0 18.8 21.2
FY: Fiscal year (October 1 through September 30)
* Includes Coast Guard.BMC Public Health 2008, 8:60 http://www.biomedcentral.com/1471-2458/8/60
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Table 2 shows the distribution of ICD-9-CM diagnostic
categories (including primary and secondary diagnoses)
for inpatient encounters during the 10 years of follow-up.
The most frequent categories were diseases of the muscu-
loskeletal system (32.7%); digestive system (23.4%);
injury and poisoning (21.0%); symptoms, signs, and ill-
defined conditions (18.7%); circulatory conditions
(14.7%); mental disorders (13.8%); and respiratory con-
ditions (12.2%). We also examined the top five primary
diagnoses within each of the 14 diagnostic categories over
the entire follow-up period (Table 3). The following
briefly describes the proportion of individuals with the
most common primary diagnoses within the categories
mentioned above. For musculoskeletal system diseases,
24.5% had a diagnosis of internal derangement of the
knee and 18.3% had intervertebral disc disorders; within
digestive diseases, 17.3% had inguinal hernia and 11.8%
acute appendicitis. Within the injury and poisoning cate-
gory, 9.2% had complications of procedures, 7.7% ankle
fractures, and 7.0% sprains and strains of the knee and
leg. For ill-defined conditions, 46.6% had respiratory sys-
tem and other chest symptoms, and 22.3% had general
symptoms. Within diseases of the circulatory system,
15.5% had cardiac dysrhythmias, 14.8% other chronic
ischemic heart disease, and 13.5% hemorrhoids, while for
respiratory system diseases, 24.3% had deviated nasal sep-
tum, 12.1% unspecified pneumonia, and 11.7% chronic
disease of tonsils and adenoids. Finally, in the category of
mental disorders, 33.1% had alcohol dependence syn-
drome and 29.6% adjustment reaction.
Examining hospitalizations at three-year intervals, the
leading diagnostic categories remained consistent over
time, although some changes occurred in rank order, and
diseases of the circulatory system gained prominence,
increasing from 9.4% in the FY 1995–1997 time interval
to 25.1% in FY 2004 (Table 2 and Figure 1). Similar pro-
portional increases occurred over time for endocrine, met-
abolic, and immunity disorders; mental disorders; and
symptoms, signs, and ill-defined conditions.
There were 4800 in-theater hospitalization records for our
study cohort. Overall, the most frequently encountered
diagnostic categories (data not shown) were injury and
poisoning (28.3%); diseases of the digestive system
(19.4%); symptoms, signs, and ill-defined conditions
(12.4%); and diseases of the musculoskeletal system and
connective tissue (12.3%). Except for differences in rank
order, these were consistent with the top four diagnostic
categories for hospitalizations during the entire follow-up
period of our study.
Time-to-event modeling was stratified by service branch
because the assumption of proportionality over time was
not met. The cumulative probability of first hospitaliza-
tion is presented in Figure 2. Long-term hospitalization
Table 2: Distribution of both primary and secondary diagnoses within 14 ICD-9-CM diagnostic categories for hospitalized individuals 
who served in the 1991 Gulf War and remained on active duty, FY 1995–2004
All years FY 1995–1997 FY 1998–2000 FY 2001–2003 FY 2004
n = 43 346 n = 30 629 n = 10 588 n = 7572 n = 1937
Diagnostic categories* %† %%% %
Infectious and Parasitic Diseases (001–139) 7.0 5.5 6.4 6.3 6.7
Neoplasms (140–239) 7.5 6.2 6.2 7.9 8.8
Endocrine, Nutritional and Metabolic Diseases, and Immunity 
Disorders (240–279)
10.4 5.8 9.4 14.7 16.9
Diseases of the Blood and Blood-Forming Organs (280–289) 5.4 3.3 5.9 6.2 5.3
Mental Disorders (290–319) 13.8 10.4 13.3 14.0 14.8
Diseases of the Nervous System and Sense Organs (320–389) 7.5 6.8 5.3 5.4 5.8
Diseases of the Circulatory System (390–459) 14.7 9.4 14.3 20.8 25.1
Diseases of the Respiratory System (460–519) 12.2 11.0 9.3 9.4 9.7
Diseases of the Digestive System (520–579) 23.4 20.1 19.6 22.4 23.4
Diseases of the Genitourinary System (580–629) 11.1 9.5 9.6 10.0 11.5
Diseases of the Skin and Subcutaneous Tissue (680–709) 5.4 4.8 3.8 4.5 4.1
Diseases of the Musculoskeletal System and Connective Tissue (710–
739)
32.7 32.1 25.6 26.0 26.1
Symptoms, Signs, and Ill-Defined Conditions (780–799) 18.7 13.0 17.1 23.2 24.2
Injury and Poisoning (800–999) 21.0 16.6 20.8 20.9 19.6
ICD-9-CM: International Classification of Diseases, 9th Revision, Clinical Modification.
FY: Fiscal year (October 1 through September 30).
* Each individual could only be counted once (primary or secondary diagnosis) within a particular diagnostic category, but could be counted in 
multiple categories.
† Percentages do not add to 100% because hospitalization for each individual could be counted in more than one category.B
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) Table 3: Top five primary diagnoses within 14 major ICD-9-CM diagnostic categories for hospitalized individuals who served in the 1991 Gulf War and remained on active 
duty, FY 1995–2004
DIAGNOSTIC CATEGORY n % DIAGNOSTIC CATEGORY n %
Infectious and Parasitic Diseases (n = 1115) Diseases of the Respiratory System (n = 2872)
Intestinal infections due to other organisms 140 12.6 Deviated nasal septum 698 24.3
Viral infection in conditions classified elsewhere and of unspecified site 140 12.6 Pneumonia, organism unspecified 347 12.1
Meningitis due to enterovirus 138 12.4 Chronic disease of tonsils & adenoids 337 11.7
Viral hepatitis 103 9.2 Other diseases of upper respiratory tract 301 10.5
Sarcoidosis 79 7.1 Chronic sinusitis 255 8.9
Neoplasms (n = 2106) Diseases of the Digestive System (n = 7446)
Uterine leiomyoma 483 22.9 Inguinal hernia 1290 17.3
Lipoma 217 10.3 Acute appendicitis 877 11.8
Benign neoplasm of bone and articular cartilage 112 5.3 Diseases of esophagus 835 11.2
Malignant neoplasm of prostate 94 4.5 Dentofacial anomalies, including malocclusion 776 10.4
Benign neoplasm of other parts of digestive system 91 4.3 Cholelithiasis 453 6.1
Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders (n = 707) Diseases of the Genitourinary System (n = 2964)
Diabetes mellitus 219 31.0 Calculus of kidney & ureter 577 19.5
Disorders of fluid, electrolyte, & acid-base balance 114 16.1 Other disorders of breast 259 8.7
Disorders of lipoid metabolism 69 9.8 Other disorders of male genital organs 231 7.8
Nontoxic nodular goiter 56 7.9 Pain & other symptoms assoc with female genital organs 225 7.6
Obesity & other hyperalimentation 54 7.6 Disorders of menstruation & other abnormal bleeding from female genital tract 142 4.8
Diseases of the Blood and Blood-Forming Organs (n = 204) Diseases of the Skin and Subcutaneous Tissue (n = 1192)
Other diseases of blood & blood-forming organs 54 26.5 Other cellulitis & abscess 559 46.9
Diseases of white blood cells 53 26.0 Pilonidal cyst 115 9.6
Purpura & other hemorrhagic conditions 33 16.2 Other disorders of skin & subcutaneous tissue 105 8.8
Iron deficiency anemias 24 11.8 Other hypertrophic & atrophic conditions of skin 97 8.1
Other & unspecified anemias 23 11.3 Diseases of sebaceous glands 85 7.1
Mental Disorders (n = 3358) Diseases of the Musculoskeletal System and Connective Tissue (n = 11 908)
Alcohol dependence syndrome 111
2
33.1 Internal derangement of knee 2920 24.5
Adjustment reaction 995 29.6 Intervertebral disc disorders 2179 18.3
Affective psychoses 689 20.5 Other derangement of joint 1302 10.9
Neurotic disorders 195 5.8 Other disorders of synovium, tendon, & bursa 1042 8.8
Depressive disorder, not elsewhere classified 170 5.1 Peripheral enthesopathies & allied syndromes 969 8.1
Diseases of the Nervous System and Sense Organs (n = 1731) Symptoms, Signs, and Ill-Defined Conditions (n = 4031)
Mononeuritis of upper limb & mononeuritis multiplex 301 17.4 Symptoms involving respiratory system & other chest symptoms 1880 46.6
Migraine 180 10.4 General symptoms 900 22.3
Mononeuritis of lower limb 163 9.4 Other symptoms involving abdomen & pelvis 481 11.9
Disorders of conjunctiva 72 4.2 Other ill-defined & unknown causes of morbidity & mortality 241 6.0
Other disorders of eyelids 71 4.1 Symptoms involving head & neck 178 4.4
Diseases of the Circulatory System (n = 2652) Injury and Poisoning (n = 6416)
Cardiac dysrhythmias 412 15.5 Other complications of procedures, not elsewhere classified 589 9.2
Other forms of chronic ischemic heart disease 393 14.8 Fracture of ankle 495 7.7
Hemorrhoids 359 13.5 Sprains & strains of knee & leg 452 7.0
Acute myocardial infarction 320 12.1 Complications peculiar to certain specified procedures 431 6.7
Varicose veins of lower extremities 144 5.4 Sprains & strains of ankle & foot 279 4.3BMC Public Health 2008, 8:60 http://www.biomedcentral.com/1471-2458/8/60
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risk was highest for Army (31% over 9.8 years) and lowest
for Marine Corps (22% over 9.7 years). Adjusted risk
ratios for selected covariates are provided in Table 4.
Female gender and being married were independent pre-
dictors of hospitalization for all services, and hospitaliza-
tion risk increased with age. There was some variability
among the service branches with respect to race and hos-
pitalization risk. For Army, those categorized as white race
had a slightly increased risk compared with black race.
Other independent predictors of hospitalization consist-
ent across services included enlisted rank and history of
in-theater hospitalization. Enlisted rank was associated
with a reduced risk of hospitalization, whereas a history of
in-theater hospitalization increased subsequent long-term
hospitalization risk. Presence in theater during ground
combat was a predictor of hospitalization for Navy only,
and combat specialists in the Air Force and Marine Corps
(but not Army and Navy) were at reduced risk of hospital-
ization compared with other occupational groups.
Discussion
Understanding the complex, interrelated health issues
associated with the 1991 Gulf War has proved challenging
and is not completely resolved. Our study focused on
describing the hospitalization experience of those who
were still on active duty at least three years following the
1991 Gulf War because of interest in retention and resil-
iency issues. We characterized those with career longevity
and examined hospitalization as an objective measure of
morbidity in this subgroup for up to 13 years following
service in the Gulf War.
Demographic and military characteristics appeared to
have influenced separation from military service more
than specific war-related exposures or experiences, with
the exception of presence in theater during the brief
ground combat phase. How these characteristics influence
separation may well represent a predictable exodus of
young, single, infantry personnel leaving the military fol-
lowing any large-scale combat operation, since significant
attrition is not surprising as an aftermath of a large mili-
tary build-up. In addition, evolving career goals, espe-
cially among young recruits completing an initial tour of
military duty, may also play an important role in losses
from the military. On the other hand, service members
who had negative experiences or poor health related to
deployment may have been more likely to separate from
military service and been lost to follow-up.
The total number of individuals hospitalized at least once
over the 10-year period of observation was 43 346 (16.4%
of the 264 409 active duty Gulf War veterans assembled
for follow-up at the start of FY 1995). This proportion is
somewhat less than the 19.4% of active duty Gulf War vet-
erans previously reported hospitalized at least once
between August 1, 1991, and July 31, 1999 [21,26]. Fit-
ness for duty standards clearly result in some premature
separations from military service due to serious medical
conditions, both physical and mental. However, it is pos-
Changes in relative proportions of selected diagnostic categories for hospitalized individuals who served in the 1991 Gulf War  and remained on active duty, fiscal years* 1995 to 2004 Figure 1
Changes in relative proportions of selected diagnostic categories for hospitalized individuals who served in the 1991 Gulf War 
and remained on active duty, fiscal years* 1995 to 2004.
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sible that the demographics of our subpopulation with
career longevity may be indicative of a healthier occupa-
tional cohort due to social and behavioral factors, not-
withstanding the expected increase in chronic medical
conditions related to advancing age over time.
Hospital discharge diagnoses (primary or secondary)
among individuals hospitalized in the current study most
frequently fell within categories related to musculoskele-
tal, digestive, injury, ill-defined, and circulatory condi-
tions (Table 2). This was not surprising for a cohort with
nearly 25% age 32 years or older at baseline (and nearly
50% 27 years or older) and aging over the 10-year period
of observation. If we consider as a point of reference, the
top five diagnostic categories for hospitalizations among
all U.S. Armed Forces during comparable time periods,
the only notable difference was in the category of mental
disorders, which was consistently under-represented in
our study population. It is noteworthy that for all of DoD,
mental disorders ranked among the top two major diag-
nostic categories (excluding pregnancy-related condi-
tions) between 2000 and 2004 [91], while for our Gulf
War-deployed, active duty subset, mental disorders did
not rank among the top five. This probably reflects some
attrition related to serious psychiatric disorders, as well as
proportional increases in those chronic conditions associ-
ated with aging. For example, circulatory conditions
steadily increased over the study period, as did diabetes,
which was the primary underlying basis for the increase
over time in the category of endocrine, nutritional, and
metabolic diseases.
Musculoskeletal conditions were the most frequent hospi-
tal diagnoses over the 10-year period of observation,
which was similar to the distribution for DoD-wide hos-
pitalizations (excluding pregnancy-related conditions)
until more recent years, when DoD numbers for this diag-
nostic category showed a relative decline [91,92]. Late
effects of injury or chronic, progressive musculoskeletal
conditions may account for continued dominance of this
diagnostic category in our study population and is also
consistent with advancing age. Further investigation of the
circumstances, as well as long-term outcomes of injury-
related musculoskeletal conditions, would be informa-
tive, and, more importantly, could result in focused pre-
vention strategies.
Our time-to-event modeling results were generally con-
sistent with a previous hospitalization study of US Gulf
War veterans covering the period from August 1991 to
July 1999 [26]. In our study, Army personnel were more
likely to be hospitalized compared with other services,
even though relative proportions of active duty service
members by service branch remained stable over time.
There were no notable differences in the distribution of
diagnostic categories for hospitalizations by service
branch that might have provided additional insight.
Cumulative probability of first hospitalization for any cause by service branch among military personnel who served in the 1991  Gulf War and remained on active duty, fiscal years* 1995 to 2004 Figure 2
Cumulative probability of first hospitalization for any cause by service branch among military personnel who served in the 1991 
Gulf War and remained on active duty, fiscal years* 1995 to 2004.
*Fiscal year is October 1 to September 30.BMC Public Health 2008, 8:60 http://www.biomedcentral.com/1471-2458/8/60
Page 9 of 13
(page number not for citation purposes)
Consistent with results from previous studies of 1991
Gulf War veterans [33,81,93] and medical surveillance
reports regarding DoD-wide hospitalization rates
[91,92,94,95], women were more likely to be hospitalized
than men. Based on available DoD-wide data, the female-
to-male crude rate ratio for hospitalizations, excluding
pregnancy-related causes, was 1.6 in 2000 and 2001 and
1.5 in 2003 and 2004 for the active duty component
[91,92,94,95]. In our study, adjusted rate ratios for
females compared with males were similar across service
branches (1.7 for Army, 1.9 for Navy, and 1.8 for Air
Force), although slightly higher (2.2) for Marines. Also,
independent of gender, married service members were
more likely to be hospitalized. Family responsibilities or
other circumstances may influence vulnerability to the
experiences of war, or perhaps married individuals may be
more likely to seek health care than their unmarried coun-
terparts.
Table 4: Adjusted risk ratios by service branch using Cox proportional hazards modeling for postwar all-cause hospitalization among 
military personnel who served in the 1991 Gulf War and remained on active duty, FY 1995–2004
Army Navy Air Force Marine Corps
Covariate RR* 95% CI † RR 95% CI RR 95% CI RR 95% CI
Gender
Female 1.70 (1.63, 1.77) 1.94 (1.78, 2.11) 1.83 (1.67, 2.01) 2.23 (1.89, 2.64)
Male Ref. Ref. Ref. Ref.
Age (years)
23–26 1.02 (0.98, 1.07) 1.02 (0.95, 1.10) 1.01 (0.91, 1.11) 1.24 (1.13, 1.37)
27–31 1.13 (1.08, 1.18) 1.13 (1.05, 1.21) 1.15 (1.04, 1.26) 1.49 (1.35, 1.65)
32–61 1.51 (1.44, 1.58) 1.51 (1.41, 1.63) 1.35 (1.21, 1.50) 2.02 (1.82, 2.24)
16–22 Ref. Ref. Ref. Ref.
Marital status
Married 1.06 (1.02, 1.10) 1.15 (1.09, 1.21) 1.10 (1.02, 1.18) 1.14 (1.06, 1.23)
Other Ref. Ref. Ref. Ref.
Race
Black 0.92 (0.89, 0.95) 0.98 (0.92, 1.03) 1.00 (0.92, 1.09) 0.98 (0.91, 1.06)
Other‡ 0.91 (0.87, 0.97) 0.71 (0.65, 0.78) 0.83 (0.70, 0.97) 0.91 (0.80, 1.04)
White Ref. Ref. Ref. Ref.
Pay grade
Enlisted 0.63 (0.60, 0.66) 0.70 (0.64, 0.75) 0.86 (0.78, 0.94) 0.78 (0.71, 0.86)
Officer Ref. Ref. Ref. Ref.
War-related exposures
Anthrax/botulinum immunization§
Yes 1.04 (0.88, 1.22) 0.91 (0.65, 1.28)
No Ref. Ref. Ref. Ref.
Exposed to Khamisiyah March 10–12, 1991#
Yes (at risk and exposed) 1.03 (0.94, 1.12) 1.01 (0.89, 1.14)
No (at risk and not exposed) 0.99 (0.91, 1.08) 1.06 (0.83, 1.35)
Never at risk Ref. Ref. Ref. Ref.
Exposed to oil well fire 1991
Yes 1.03 (0.99, 1.07) 0.97 (0.92, 1.02) 0.96 (0.90, 1.03) 1.04 (0.96, 1.13)
No Ref. Ref. Ref. Ref.
In-theater hospitalization
Yes 1.60 (1.49, 1.71) 1.71 (1.41, 2.07) 1.50 (1.31, 1.73) 1.78 (1.48, 2.14)
No Ref. Ref. Ref. Ref.
In theater during combat period
Yes 0.94 (0.86, 1.03) 1.07 (1.02, 1.13) 0.96 (0.84, 1.09) 0.99 (0.90, 1.09)
No Ref. Ref. Ref. Ref.
Occupation
Combat specialists 1.01 (0.97, 1.04) 1.05 (0.99, 1.12) 0.82 (0.74, 0.92) 0.92 (0.86, 0.99)
Other Ref. Ref. Ref. Ref.
FY: Fiscal year (October 1 through September 30).
* RR: risk ratio; adjusted for all other covariates in the model.
† CI: Confidence interval.
‡ Other: heterogeneous group, including Asian American, Hispanic, and Native American, among others.
§ Immunizations data not complete.
# Only Army and Air Force data available for Khamisiyah munitions demolition exposure.BMC Public Health 2008, 8:60 http://www.biomedcentral.com/1471-2458/8/60
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We found no increased risk of hospitalization associated
with either potential exposure to nerve agents at Khamisi-
yah or smoke from oil well fires, again consistent with ear-
lier hospitalization studies [26,29,33]. On the other hand,
in-theater hospitalization was a predictor of long-term,
postwar hospitalization across all service branches. This
finding has not been previously reported. Because ascer-
tainment of in-theater hospitalizations was not complete
[28], we may have underestimated the magnitude of the
association between this and subsequent long-term hos-
pitalization. This finding may warrant further investiga-
tion.
Among those who were present in theater during ground
combat, there was some variation in the risk of long-term
hospitalization by service branch. Navy personnel had a
slightly increased risk, while for Army and Air Force, the
risk was reduced but not statistically significant. A possi-
ble explanation is that in-theater Navy personnel who go
ashore tend to be elite combatants or part of construction
battalions known as Seabees. Gray et al. reported that Sea-
bees deployed to the Gulf War were more likely to self-
report smoking, newly diagnosed digestive diseases or
depression, and one or more hospitalizations since
August 1990, compared with Seabees deployed elsewhere
or not deployed [96].
Finally, occupation was a risk factor for long-term hospi-
talization only for Marines and Air Force personnel, with
combat specialists having a reduced risk. We might sur-
mise that combat specialists in the Air Force are more
likely to include individuals with technologically
advanced training and education, who may typify a health
and safety-oriented group. Similarly, frontline Marine
combatants may belong to a sub-population that selects
for those with lower long-term hospitalization risk. Over-
all, the Marines had a lower cumulative probability of
hospitalization than the other services.
The strengths of our study include 10 years of follow-up
of a well-defined population of active duty service mem-
bers from the 1991 Gulf War cohort with near complete
ascertainment of an objective health outcome measure.
On the other hand, we did not have a comparison group
of non-deployed service members from the same era, nor
could we ascertain hospitalizations among service mem-
bers in our study cohort who separated from military serv-
ice. Thus, restricting our analyses to Gulf War-deployed,
active duty personnel introduced a selection bias and is a
limitation of our study. Individuals with serious and
debilitating injuries or illnesses following deployment
would not meet fitness for duty standards, most likely
leading to separation from military service. Additionally,
once individuals are separated from the military, com-
plete hospitalization data for are not readily accessible for
analysis. Finally, hospitalization is only a partial measure
of long-term morbidity, and other sources, such as auto-
mated ambulatory data, might provide additional insight.
Conclusion
We provide a description of the overall long-term hospi-
talization experience in the subset of Gulf War veterans
with military service longevity. Intra-cohort comparisons
by service branch present information on the influence of
Gulf War-related exposures and experiences on subse-
quent long-term hospitalization. Multivariable modeling
suggests that in-theater hospitalization was the only sig-
nificant independent predictor of long-term hospitaliza-
tion risk among the selected war-related exposures or
experiences examined. Although analyses were limited to
Gulf War-deployed veterans who remained on active duty,
our results offer some insight into the relative importance
of predictors for long-term morbidity within this subset
using an objective outcome measure. Additionally, this
investigation adds to our understanding of retention and
resiliency following large-scale combat operations.
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